Feature Articles

Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine

High Hopes

Hematology patients are turning to cannabis for symptom relief, but should they? As of October 2017, 28 states and the District of Columbia had...

A Behind-the-Scenes Look at the ASH Annual Meeting

Every December, tens of thousands of researchers, clinicians, and health-care stakeholders gather for the American Society of Hematology’s (ASH) annual meeting. More than a...

Off to the CAR T Races: Bringing CAR T-Cell Therapies to Cancer Patients

August 30, 2017, marked a milestone for medicine: The cell-based gene therapy tisagenlecleucel became the first U.S. Food and Drug Administration (FDA)–approved treatment that...

The Pains of Opioid Prescribing

The United States is in a state of emergency: The Centers for Disease Control and Prevention (CDC) estimates that 91 Americans die each day...

The Rank Tank

Are public health-care ratings an indicator of quality or of popularity? Each summer, U.S. News & World Report releases its list of the best hospitals...

Mining the “Gold Rush” of Immunotherapy Clinical Trials

Immunotherapy has the potential to revolutionize cancer treatment, but as the number of immunotherapy clinical trials continues to grow, so do the challenges and...

Entering A New Era of Immunotherapy

On August 30, 2017, the FDA approved the first gene therapy in the United States: Tisagenlecleucel (Kymriah, Novartis) is a CD19-directed CAR T-cell therapy...

Rewriting the Rules of Informed Consent

A look at efforts to include individuals with intellectual and developmental disabilities in clinical research When hematologist/oncologist Cecilia Arana Yi, MD, first saw George (name...

The Geography of Drug Approvals

How can regulators look at the same data and get different results? The goal of regulatory bodies such as the U.S. Food and Drug Administration...

It Runs in the Blood

For these doctors, hematology is “the family business” The term “family business” may conjure images of stores, restaurants, and other commercial enterprises, but it turns...
Advertisement

Current Issue

November 2017, Volume 3, Issue 13

This issue features a behind-the-scenes look at the ASH annual meeting, bringing newly approved gene therapies to patients, and more.